Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Smith & Wesson Brands Inc is an aerospace & defense business based in the US. Smith-and-Wesson Brands shares (SWBI) are listed on the NASDAQ and all prices are listed in US Dollars. Smith-and-Wesson Brands employs 2,236 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$21.70|
|52-week range||$14.37 - $39.46|
|50-day moving average||$21.50|
|200-day moving average||$22.35|
|Wall St. target price||$31.80|
|Dividend yield||$0.23 (1.07%)|
|Earnings per share (TTM)||$5.24|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||3.14%|
|1 month (2021-09-20)||4.18%|
|3 months (2021-07-20)||-12.15%|
|6 months (2021-04-20)||20.96%|
|1 year (2020-10-20)||26.46%|
|2 years (2019-10-18)||313.35%|
|3 years (2018-10-19)||102.96%|
|5 years (2016-10-20)||5.97%|
Valuing Smith-and-Wesson Brands stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Smith-and-Wesson Brands's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Smith-and-Wesson Brands's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Smith-and-Wesson Brands shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Smith-and-Wesson Brands's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $387.1 million.
The EBITDA is a measure of a Smith-and-Wesson Brands's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.1 billion|
|Operating margin TTM||32.36%|
|Gross profit TTM||$459.5 million|
|Return on assets TTM||38.79%|
|Return on equity TTM||75.2%|
|Market capitalisation||$1 billion|
TTM: trailing 12 months
There are currently 3.7 million Smith-and-Wesson Brands shares held short by investors – that's known as Smith-and-Wesson Brands's "short interest". This figure is 14.9% down from 4.3 million last month.
There are a few different ways that this level of interest in shorting Smith-and-Wesson Brands shares can be evaluated.
Smith-and-Wesson Brands's "short interest ratio" (SIR) is the quantity of Smith-and-Wesson Brands shares currently shorted divided by the average quantity of Smith-and-Wesson Brands shares traded daily (recently around 1.5 million). Smith-and-Wesson Brands's SIR currently stands at 2.47. In other words for every 100,000 Smith-and-Wesson Brands shares traded daily on the market, roughly 2470 shares are currently held short.
However Smith-and-Wesson Brands's short interest can also be evaluated against the total number of Smith-and-Wesson Brands shares, or, against the total number of tradable Smith-and-Wesson Brands shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Smith-and-Wesson Brands's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Smith-and-Wesson Brands shares in existence, roughly 80 shares are currently held short) or 0.0847% of the tradable shares (for every 100,000 tradable Smith-and-Wesson Brands shares, roughly 85 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Smith-and-Wesson Brands.
Find out more about how you can short Smith-and-Wesson Brands stock.
Dividend payout ratio: 4.88% of net profits
Recently Smith-and-Wesson Brands has paid out, on average, around 4.88% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.48% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Smith-and-Wesson Brands shareholders could enjoy a 1.48% return on their shares, in the form of dividend payments. In Smith-and-Wesson Brands's case, that would currently equate to about $0.23 per share.
While Smith-and-Wesson Brands's payout ratio might seem low, this can signify that Smith-and-Wesson Brands is investing more in its future growth.
Smith-and-Wesson Brands's most recent dividend payout was on 27 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 12 September 2021 (the "ex-dividend date").
Smith-and-Wesson Brands's shares were split on a 1301:1000 basis on 24 August 2020. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1301 shares. This wouldn't directly have changed the overall worth of your Smith-and-Wesson Brands shares – just the quantity. However, indirectly, the new 23.1% lower share price could have impacted the market appetite for Smith-and-Wesson Brands shares which in turn could have impacted Smith-and-Wesson Brands's share price.
Over the last 12 months, Smith-and-Wesson Brands's shares have ranged in value from as little as $14.3701 up to $39.4604. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Smith-and-Wesson Brands's is 0.8032. This would suggest that Smith-and-Wesson Brands's shares are less volatile than average (for this exchange).
Smith & Wesson Brands, Inc. designs, manufactures, and sells firearms worldwide. The company offers handguns, including revolvers and pistols; long guns, such as modern sporting rifles, bolt action rifles, and muzzleloaders; handcuffs; suppressors; and other firearm-related products under the Smith & Wesson, M&P, Performance Center, Thompson/Center Arms, and Gemtech brands. It also provides manufacturing services comprising forging, heat treating, rapid prototyping, tooling, finishing, plating, machining, and custom plastic injection molding to other businesses under the Smith & Wesson and Smith & Wesson Precision Components brand names; and sells parts purchased through third parties. The company sells its products to firearm enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, law enforcement, security agencies and officers, and military agencies. It markets its products through independent dealers, retailers, in-store retails, and direct to consumers; print, broadcast, and digital advertising campaigns; social and electronic media; and in-store retail merchandising strategies. The company was formerly known as American Outdoor Brands Corporation and changed its name to Smith & Wesson Brands, Inc.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.